Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2025 Earnings Call Transcript May 13, 2025
Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.1.
Operator: Welcome to the Lexicon Pharmaceuticals First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a brief question-and-answer session. As a reminder, this call is being recorded...
